Lifescience
Home Insemination Market Size Forecast to Reach $2.3 Billion by 2025
Home Insemination Market size is forecast to reach $2.3 billion by 2025, growing at a CAGR of 6.8% during the forecast period 2020-2025. Home insemination is a type of artificial insemination done usually by woman at home. Artificial insemination is a fertility treatment method used to deliver sperm directly to the cervix or uterus in the hopes of getting pregnant. Sometimes, these sperm are washed or “prepared” to increase the likelihood a woman to get pregnant. For many reasons, at-home insemination is a preferred option for many women in a variety of situations. One of the main benefits of performing artificial insemination at home is the comfort, privacy, and ideal timing it provides. Women predominantly prefer Turkey Baster Method, Cervical Cap and instead cup for artificial insemination at home. However, doctors usually instruct to use germicidal soap before using the equipment at home for better sterilizing from germs. Changing lifestyle standards, lower cost in comparison to other fertilization procedures, growing cases of male and female infertility and favorable government laws in developed countries for fertility procedures are driving the market growth in recent years. In addition, major market development of key players like Conceivex, Inc. are other factors driving the growth of the market.
Key Takeaways
- North America dominated the Home Insemination Market in the year 2019 owing to increasing demand for Home Insemination by single mothers and lesbian couples, increasing prevalence of infertility among adults and increasing key developments by market players. The Home Insemination Market scope for different regions will be provided in the final report.
- Increasing prevalence of infertility, growing awareness about single parenthood and same-sex parenthoods, well developed healthcare infrastructure in developed countries, improving economic and average disposable income and favorable government policies for fertility law have helped in significant growth of Home Insemination Market.
- Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Home Insemination Market report.
- Stringent government laws on fertility in some developing countries are anticipated to hamper the market growth of the Home Insemination Industry.
- Increasing prevalence of infertility
- Growing awareness about single parenthood and same-sex parenthoods
- Stringent government laws on fertility in some developing countries
- In April 2017, FDA approved take-home kit by Conception Kit, an innovation in fertility artificial insemination for dummies.
- In August 2017, Conceivex announced that its signature product, The Conception Kit® at-home system, an FDA cleared, affordable at-home treatment for infertility would be available through a new partnership with online and mail-order pharmacy HealthWarehouse.com. Conceivex and HealthWarehouse.com had signed National Distribution Agreement for the product’s sales expansion.
- In August 2015, Rinovum Women's Health Company, launched its flagship product, The Stork OTC home conception aid in Australia.






